XT
DRNA

XTX Topco’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

XTX Topco’s Portfolio DRNA Stock Details DRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-17,008
Closed -$343K – 1101
2021
Q3 		$343K Buy
+17,008
New +$470K 0.12% 306

Other funds holding DRNA

CAM
Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

XTX Topco's DRNA Position: Q4 2021 in Review

XTX Topco sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 17,008 shares — an estimated $343K sold.

XTX Topco first reported a position in DRNA in Q3 2021 and held it in 1 quarter. The position peaked at $343K in Q3 2021. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

  • XTX Topco reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
  • XTX Topco sold 17,008 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $343K.
  • XTX Topco first reported a position in Dicerna Pharmaceuticals, Inc. in Q3 2021 and held it in 1 quarter.
  • XTX Topco's Dicerna Pharmaceuticals, Inc. position peaked at $343K in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on XTX Topco's 13F filing for Q4 2021, filed 11 Feb 2022.